Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Mintreleq XL 300 mg prolonged-release tablets

Active Ingredient:
quetiapine fumarate
Company:  
Aristo Pharma Limited See contact details
ATC code: 
N05AH04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Mintreleq XL (Quetiapine MR) Risk Management Plan for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
Information for Healthcare Professionals to help inform patients, their families, and their caregivers about the benefits and the risks associated with quetiapine treatment.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Aristo Pharma Limited
Company image
Address
The North Suite, Avro House, 49 Lancaster Way Business Park, Ely, Cambridgeshire, CB6 3NW, UK
Telephone
+44 (0)1353 887 100
Medical Information Direct Line
01483 920754
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1353 887 100
WWW
www.aristo-pharma.co.uk